chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash over whole body.  Bright red splotches. Went to an Urgent Care Facility 11:00am April  10. Received a Steroid shot and Perscription for 6 day Methylprednisolone 4mg 21 tablets which I end tomorrow. Plus Hydroxyzine 25 mg tablets for itching.  Have no other symptoms, have no idea related to vaccine. Rash has not disappeared, itching has subsided. Reporting only because asked to do so. No concern or alarm.
CHILLS AND LOW GRADE TEMP. 100 DEGREES. 10:00 pm the next day after the injection.  About 37hrs.
pt recv vax 1AUG96 & pox noted 13MAR99 had less than 1 dozen pox erupted over 4 days;
Tested positive for Covid; This is a spontaneous report from a contactable nurse (patient). A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982 and expiry date: Apr2021), via an unspecified route of administration on 20Jan2021 at single dose for COVID-19 immunization. Medical history was reported as none.  There were no concomitant medications. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient stated, "I received the vaccine on 20Jan2021, Pfizer at my work at (Facility name) and then I just tested positive for COVID on 20Jan2021. So, how will that effect my second dose?" When asked about treatment, the patient stated, "I do not know. Is Tylenol also considered as a treatment?" And when asked about causality, the patient stated, "I think so, I mean I do not want to rule that out, but maybe." The outcome of the event was unknown.
Left shoulder pain after receiving flu shot on 10/05/2016. Limited range of motion, unable to raise arm above shoulder level without pain.
Information has been received from a pharmacist referring to a female patient of unknown age. Information about concomitant medication, concurrent condition and medical history was not provided. On 29-OCT-2018, the patient was vaccinated with an improperly stored PNEUMOVAX 23 intramuscularly, lot # R022249, expiration date 16-APR-2020 for prophylaxis (strength, dose detail and anatomical location were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 47 Fahrenheit (F) and 77 F (average 70 F) for a time frame of 1 hour without previous temperature excursion. Data logger was not involved.
Initial information received on 18-Mar-2019 regarding an unsolicited valid non-serious case received from a physician. This case is linked to cases 2019SA077925 and 2019SA077920 (same reporter). This case involves a 6 months old male patient who received a dose of IPOL lot N1J451M, expiration date: 05-Oct-2019 via unknown route in unknown administration site on 29-Jan-2019. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was an actual medication error due to product storage error. IPOL vaccine that reached a temperature of 34-33 degrees F was administered to a 6 month old male patient on 29-Jan-2019. It was unknown whether patient experienced any adverse event following vaccination. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Report she got the vaccine on 4/10/21 and started having achiness, fatigue shortly after. 3 days later pt developed diarrhea (watery), cough, SOB. Reports SOB worse with exertion, talking.
Vaccine injected into left deltoid. Pt developed red swollen rash on left bicep. By 9/29/16 swelling decrease, rash is tender to touch and red and warm about 6 inch by 6 inch size.
pt c/o ankle pain 1wk p/vax;afeb had malaise;
Patient received her 2 month old vaccines on 7/8/13. Per mom, 4 hrs after receiving vaccinations, baby stated crying excessively then turned "white and pale", no cyanosis, then turned weak, seemed to pass out few seconds. Mom called paramedic. Baby was doing well when paramedic arrived and continues to do well except for >1 fever, TYLENOL helps.
I had a bad headache the first night. The next morning, I woke up with a sore throat. That afternoon, I started running 101 or 102 temp. I was coughing and would bring up mucus a few times a day. It was mostly a dry cough. I had extreme fatigue. I was very dizzy. My sore throat progressed. On Friday the 27th, I couldn't drink anything. My throat was sore it was almost closed. I was really dehydrated. I had a telehealth appointment with urgent care that morning. They told me to go to the emergency room. I was still running high temperatures that day. I was there for 13 hours. They ended up giving me an IV, steroids, and lidocaine gel for my throat. I called my doctor on Wednesday and had a telehealth visit. They prescribed Paxlovid so I had already started that. I was better on Saturday. I went back to urgent care on Monday because I was so dizzy, I couldn't walk across the room. My heart rate was in the 50s. They did an EKG. My heart rate was bradycardic. I had a telehealth appointment a few days later, and my heart rate was much better. It took a couple of weeks to a month to feel better. I'm still not 100%. I get tired easily. I had to use my albuterol inhaler when I was sick. I was having chest pains when I went to the ER, too. They did cardiac enzymes.
Initial report received 18 December 2009 from a health care professional. A two-year-old female patient with no known allergies had received a second dose intramuscular right thigh injection of Influenza A (H1N1) 2009 Monovalent Vaccine - Preservative, lot number UP019AA on 17 December 2009 and within 15 minutes of vaccination, she developed itchy hands and hive like swelling around her mouth and on her chin with no respiratory distress. The patient was sent to the emergency room and received corrective treatment with an Epipen and BENADRYL. A few hours after release, the symptoms restarted and the patient returned to the emergency room. The patient was admitted and remained hospitalized at the time of the report. At the time of vaccination, the patient had no concurrent illness, no medical conditions, and she had not been taking any concomitant medications. The patient had previously received a first dose intramuscular left thigh injection of Influenza A (H1N1) 2009 Monovalent Vaccine - Preservative, lot number UP019AA on 11 November 2009. She had no reported adverse events following prior vaccinations. At the time of the report, the patient had not recovered. Documents held by sender: None.
The patient experienced numbness and soreness in her arm a few days following vaccination. She also experienced a stiff neck which she treated with an ice pack.
spoke  to MD 2 d ago re: local reaction at site of varivax: quarter sized minimally tender/ minimally red: assumed "local reaction"; today mom called e "one" teenyvesical at site: allow "nontransmissible"..will attempt to confirm and respond accordingly.
Narrative: Patient reported injection site pain following administration of 2nd dose of Pfizer covid vaccine. Patient required no intervention and was able to leave following normal monitoring period.
The same day of vaccination, the pt experienced inflammation and tenderness. On 9/28/99, the pt reports area still sore to the touch with pain in back and down arm, especially when lifting objects. It was reported that are unable to obtain further information on phone call.
sat up from lying down and was very lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (sat up from lying down and was very lightheaded) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included Glaucoma, Venous bleeding (optic vein in right eye burst) and Surgery (quadruple ablation performed). Concurrent medical conditions included Flu vaccination and Pneumococcal immunization (Allergic to Prevnar-13 (Pneumococcal) vaccine). Concomitant products included APIXABAN (ELIQUIS), CARVEDILOL, PRAVASTATIN, EZETIMIBE (ZETIA), CALCITRIOL, AFLIBERCEPT (EYLEA) and LATANOPROST for an unknown indication.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced DIZZINESS (sat up from lying down and was very lightheaded). At the time of the report, DIZZINESS (sat up from lying down and was very lightheaded) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Blood pressure measurement: Blood pressure 113/73 reported. On 14-Feb-2021, Heart rate: Heart rate reported 73..         This case was linked.
Patient reported red mark the size of a baseball on her arm where she received the injection. She said it does not hurt and does not itch.
BACK IN FEBRUARY PATIENT WAS IN A NURSING HOME. HE IS HOME NOW AND HIS MOM BROUGHT HIM IN FOR WHAT SHE THOUGHT WAS HIS 1ST COVID VACCINATION. HE DIDN'T REMEMBER RECEIVING THE 1ST DOSE BUT IT IS DOCUMENTED IN THE DATA BASE.  THE FAMILY UNDERSTANDS HE HAS HAD 2 SHOTS OF DIFFERENT MANUFACTURERS AND THE SERIERS IS COMPLETE.
had swollen eyelids; fever 99F; cough; some pain in the kidneys; agitaded breath; fogginess; tiredness; difficulty sleeping; chills; congestion in his nose; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion in his nose), FEELING ABNORMAL (fogginess), INSOMNIA (difficulty sleeping), COUGH (cough) and DYSPNOEA (agitaded breath) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Medullary sponge kidney.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced NASAL CONGESTION (congestion in his nose). On 27-Mar-2021, the patient experienced INSOMNIA (difficulty sleeping) and CHILLS (chills). On 28-Mar-2021, the patient experienced FEELING ABNORMAL (fogginess) and FATIGUE (tiredness). On 01-Apr-2021, the patient experienced DYSPNOEA (agitaded breath). On 02-Apr-2021, the patient experienced RENAL PAIN (some pain in the kidneys). On an unknown date, the patient experienced COUGH (cough), SWELLING OF EYELID (had swollen eyelids) and PYREXIA (fever 99F). The patient was treated with IBUPROFEN for Fever, at a dose of 2 half pills. On 29-Mar-2021, INSOMNIA (difficulty sleeping) had resolved. At the time of the report, NASAL CONGESTION (congestion in his nose), FEELING ABNORMAL (fogginess), COUGH (cough), DYSPNOEA (agitaded breath), RENAL PAIN (some pain in the kidneys), SWELLING OF EYELID (had swollen eyelids), CHILLS (chills), FATIGUE (tiredness) and PYREXIA (fever 99F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Mar-2021, Body temperature: 99 (High) 99 F. On 29-Mar-2021, SARS-CoV-2 test: negative (Negative) Negative.         Concomitant medications were not provided.  For mRNA-1273 (COVID 19 Vaccine Moderna), the reporter did not provide any causality assessments.    This case was linked to MOD21-068246 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow up received on 29-JUN-2021 contained non-significant information.
VASOVAGAL SYNCOPE EPISODE LASTED FOR AT LEAST 5 SECONDS. PATIENT TRANSPORTED VIA WHEELCHAIR IN THE TREATMENT WITH MOM. VITAL SIGNS TAKEN (BP80/50;PR 82;RR12;T 97.1;O2SAT 94%. APPLIED ICE PACK ON BACK OF NECK AND FOREHEAD. NO DIZZINESS, N/V,SOB/DYSPNEA, CHEST PAIN, DENIES WEAKNESS, NO COLD CLAMMY SKIN, NO LABORED BREATHING. NO HIVES. NO OTHER SXS NOTED/REPORTED. OFFERED SIPS OF WATER WHICH PATIENT TOLERATED. STAYED WITH PATIENT FOR 20 MINUTES RECHECKED VITAL SIGNS STABLE ( BP 90/56;PR86;RR16;O2SAT 100%). SKIN LOOKS NORMAL AND PATIENT STATES FEELS MUCH BETTER. ASKED TO SIT UP PATIENT TOLERATED AND ABLE TO AMBULATE WITH MOM. REVIEWED WITH MOM THE VISs AND TO SEEK ER CARE/CALL CLINIC IMMEDIATELY IF PATIENT HAVING SERIOUS ALLERGIC REACTION.
STABLE ANGINA ACUTE NON ST ELEVATION MI ALLERGIC REACTION, INIT
Pt returned to the pharmacy to inquire about vaginal bleeding being a SE. I asked if it could be her period. She states her period was 2 weeks ago and no. I explained it has been noted to bring on menstrual cycle early, but not likely 20 minutes after her dose. She asked me to file the VAERS.
Information has been received from a healthcare professional via Pfizer (manufacturer report number: 2015377806), referring to a currently 18 year old male patient of unknown age. No relevant medical history or concurrent conditions were reported. On an unknown date, at least a year ago, the patient was vaccinated with GARDASIL 9 (manufacturer unknown) (dose, route, lot#, expiration date were not reported). On an unknown date the patient fainted when he received GARDASIL 9 (manufacturer unknown). The outcome of the event was unknown. Causality assessment was not reported. Additional information has been requested.
I developed Covid with symptoms approximately 2 days after vaccination.  Symptoms were similar to a bad case of bronchitis, severe headaches, coughing, wheezing.  Never had a temperature.
Got Pfizer and Moderna; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Got Pfizer and Moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and first dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Got Pfizer and Moderna). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Got Pfizer and Moderna) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant drugs were reported.  No Treatment information  were reported.
States had small, hard ball @ inj. site immediately after on L arm. In last couple days, area now equals half-dollar sized hard, red area with heat.  Also has redness 3 to 4 inches around arm.  Area around hard spot itches, although the hard spot does not itch.
patient states after the vaccine was given she had a lot of pain at the site. Patient then began to notice redness & swelling at the site a couple of days later. patient states body aches, fatigue, and cramping & diarrhea.
3/31/21 sore throat, low grade fever, cough, post nasal drip, achy, neg. strep, neg Covid.  Lasted for 6 weeks despite 3 rounds of antibiotics and 1 round of steroids given by pulmonologist.
Localized skin reaction with erythema, warmth, "feels like a knot under skin" at the vaccination site, and itching. No treatment other than observation for worsening symptoms.
Back pain; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain) and PAIN IN EXTREMITY (Arm pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back pain) and PAIN IN EXTREMITY (Arm pain). At the time of the report, BACK PAIN (Back pain) and PAIN IN EXTREMITY (Arm pain) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications have been reported.
VACCINE ADMINISTERED@ COUNTY HEALTH DEPT 10/18/2000 PRESENTED IN OFFICE 05/17/2005 WITH PAPULES DX;VARICELLA >50 LESIONS HAD MMR,DTAP,IPOL ON 11/09/2000
Patient had Pneumovax on 12/21/04. Developed swelling in upper right arm going down to elbow area.
1. I had shortness of breath following the vaccine. Ignored the symptoms but recall asking others if they were having similar symptoms. I couldn?t climb more than 3 flights of stairs without becoming short of breath which is unusual for me.  2. I have started having extremely heavy periods. To the point where in 30 min I am bleeding through a 9 hour pad and staining my clothes. This is also extremely unusual for me.
Patient received vaccine and 10 minutes into waiting period, he began to slouch in chair and he dropped his belongings.  We got to him quickly and held him up while it appeared he was fainting.  We lowered him to the ground and called 911 and his father that was in store .  He complained of being very hot and dizzy.  He began to recover fairly quickly,  he drank some water and stayed on floor.  His dad arrived and the 911 call was cancelled due to his improving awareness.  He stayed in the lobby  for 20-30 minutes.  He felt much better and left with his dad in good physical condition.
Pt w/ a hx of allergy to cows milk (SOB, abdominal disorder, fatigue). PMH significant for anxiety, panic attacks, depression, is currently on disability d/t extreme fatigue (most likely brought on by depression and anxiety), and ongoing SOB. Current Medications: Albuterol 90mcg/act 1-2 inh Q6hrs PRN Wheezing Vitamin D3 400units PO Daily Restasis 0.05% unknown frequency  16mins post vaccination, pt c/o nausea, soreness at the vaccination site, feeling feverish, and overall "not feeling good".  Pt brought to the triage area from the observation area. Vitals @12:52pm BP 106/74, HR 73, RR 14 Pt assessed and monitored by nurse and NP.  Pt states that he is feeling better and improving.  Released from vaccination site in stable condition and recommended to f/u w/ PCP.  F/u instructions provided.  Of note, the morning of the patient's COVID vaccination, pt was seen for PFTs due to ongoing SOB.  During that test, the patient experienced anxiety and a panic attack after one attempt of spirometry.  Vitals at that time: BP 119/73, HR 88, SpO2 100%.  Staff offered transport to the ED or 911 call due to his complaint of chest pain and difficulty breathing.  Pt refused, indicating that this is a common occurence but no one can figure out what is wrong with him. Pt was able to follow instructions to slow down his breathing and follow commands.  Pt remained in the pulmonary clinic for 30 mins.  Discharge vitals: BP 119/73, HR 101, RR 24, O2Sat 100% RA.  Shortly after leaving the PFT appointment, the pt arrived at the Covid vaccination clinic located onsite.
headaches; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headaches".  Additional information: The reporter said he talked to 200 people who have a headaches from that booster shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300034302 Same reporter/ drug/ event for different patients;
I missed my second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I missed my second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I missed my second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I missed my second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Patient took the first dose and travelled due to family emergency and missed second dose. No treatment information was provided.
Left eye twitching began within 24 hours and continues to this day 15 days later Menstruation started early, is heavier, and has continued for 15 days Wakes up with numb hands
Onset of erythema 8 days after dose, afebrile, c/w COVID arm.
3-inch diameter redness, swelling, hot to touch at vaccination site beginning about 10 pm. General itching and some bumps on skin on neck and arms
2 weeks after shot Very Lethargic - cold - tired - head ached for short periods 1-2 minutes but intense as if brain swelling or shrinking. Next day pus nodules on back of throat.  5 days later I was fine.
Patient was given 2nd primary (monovalent) dose of Moderna .25 was given to after the patient was 6 years old. No known VERS experienced by patient, This was an Vaccine error. Patient first dose was given on  3-4-2023.
Redness and firmness with pain on palpation left deltoid. Cool packs 15 min 9.2 - BENADRYL 25 mg tid x 2 day.
This 92 year old female received the Covid shot on  3/16/21    and went to the ED on 4/2/21     and was admitted  on 4/2/21 with the following diagnoses listed below. R65.10 - SIRS (systemic inflammatory response syndrome) (CMS/HCC) E87.1 - Hypo-osmolality and hyponatremia
Why does the body feel strange or weird after having the first vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Why does the body feel strange or weird after having the first vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Why does the body feel strange or weird after having the first vaccination). At the time of the report, FEELING ABNORMAL (Why does the body feel strange or weird after having the first vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment medicines relevant to events were not reported.
pt recv vax 17NOV94 & 23NOV94 the pt devel three red, itchy spots on the lt arm, leg & 2 similar spots on the lt arm; No further details were provided;
pt recv vax & broke out in purpura which covered trunk & legs;pt was hosp MD states that no further info is available;